India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#182- Valuation
- ₹33,320 Cr
Please enter your name.
Please enter a valid email address.
Please select an issue type.
Please add a few details about the issue.
About Aristo Pharmaceuticals
Aristo Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1971. Pharmaceutical manufacturing and innovation in various therapeutic segments are conducted by Aristo Pharma. The company has 4,171 employees. Its website aristopharma.co.in draws about 27 thousand monthly visits. Its Indian entity Aristo Pharmaceuticals Private Limited reported revenue of ₹5,363 Cr. Aristo Pharmaceuticals offers products and services including ProGG and MONOCEF. Its focus areas include Research and Development, Innovation Services, Product Differentiation and Pharmaceuticals.
Company details
It is observed that Aristo Pharma is positioned as a key player in the Indian pharmaceutical market, holding ranks such as 3rd in its covered market and 5th in prescription audits, with revenues exceeding 5700 crores as per IQVIA data. The company has launched innovative products like ProGG, the worlds leading probiotic, and has introduced over 21 formulations first in India, spanning areas like anti-infectives and gastro intestinal therapies. Growth is demonstrated through a 10.76 CAGR over five years, supported by a sales force of 5100, while operating with seven marketing divisions to maintain a strong market presence.
Recognitions & Rankings of Aristo Pharmaceuticals
- Headquarters Mumbai, India
- Employees 4,171
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website aristopharma.co.in
- Social LinkedIn Facebook
- Legal Name Aristo Pharmaceuticals Private Limited
- Date of Incorporation 08 Nov, 1971
- Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Key Metrics
- Annual Revenue₹5,363 Cr
FY 2025 · +5% YoY
- Net Profit₹1,701 Cr
FY 2025 · 34% margin
- EBITDA₹2,362 Cr
FY 2025 · 48% margin
- Employee Count4,171
Associated legal entities of Aristo Pharmaceuticals
Aristo Pharmaceuticals operates through Aristo Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aristo Pharmaceuticals Private Limited CIN U24239MH1971PTC015425 | Active | 08 Nov 1971 | Mumbai, Maharashtra | ₹5,363 Cr | 9,848 | 3 | View details |
Products & Services of Aristo Pharmaceuticals
Aristo Pharmaceuticals offers a comprehensive portfolio of products and services, including ProGG and MONOCEF.
ProGG
Probiotics
Probiotic products are offered that include the L. rhamnosus GG formulation
MONOCEF
Antibiotics
Antibiotic products are provided that encompass ceftriaxone-based formulations
Board of directors of Aristo Pharmaceuticals Private Limited (Aristo Pharmaceuticals)
Aristo Pharmaceuticals Private Limited is the primary company behind Aristo Pharmaceuticals. The board of Aristo Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Umesh Sharma, appointed in 1979. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Umesh Sharma DIN 01385819 | Managing Director | 12 Feb 1979 | 47 yrs 9 mo | Aristo Pharmaceuticals Private Limited |
| Randhir Kumar Bachan DIN 01163058 | Whole-time director | 01 Sep 2005 | 21 yrs 2 mo | Aristo Pharmaceuticals Private Limited |
| Virendra Sharma DIN 01449416 | Director | 03 Oct 2006 | 20 yrs 1 mo | Aristo Pharmaceuticals Private Limited |
Financials of Aristo Pharmaceuticals
Figures of Aristo Pharmaceuticals Private Limited, the primary company behind Aristo Pharmaceuticals, for FY 2025. Revenue was ₹5,363 Cr (+5% year on year). Net profit was ₹1,701 Cr (34% margin). EBITDA was ₹2,362 Cr (48% margin). Revenue has grown at a compounded annual rate of +8% over three years and +11% over five years.
- ₹5,363 CrRevenue · FY 2025 · +5% YoY
- ₹1,701 CrNet profit · 34% margin
- ₹2,362 CrEBITDA · 48% margin
- ₹99 LakhPaid-up capital
- 9,848Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aristo Pharmaceuticals Private Limited are on its company page.
Premium access
Detailed financial statements for Aristo Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Aristo Pharmaceuticals
The website of Aristo Pharmaceuticals (aristopharma.co.in) receives about 27.4K visits a month and ranks #1,289,051 among all websites worldwide, #1,645 in Biotechnology and Pharmaceuticals.
- Monthly visits27.4K
▲ 51.6% vs previous month
- Unique visitors8.1K
per month
- Global rank#1,289,051
among all websites
- Category rank#1,645
Health · Biotechnology and Pharmaceuticals
Visitor engagement
- Bounce rate53%
- Pages per visit2.5
- Average visit3 min 11 sec
- DevicesDesktop 42% · Mobile 58%
Similar websites
Websites whose visitors overlap most with Aristo Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aristo-pharma.de | 100% | #1,744,648 | View details | ||
| titaneyeplus.com | 36% | 1.3M | #30,473 | View details | |
| aristo-india.com | 34% | 17.7K | #860,409 | View details | |
aristo.com | aristo.com | 30% | #5,087,398 | – |
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as Aristo Pharmaceuticals (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 74.68 M | 1,618 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Upgrade to premium
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aristo Pharmaceuticals
Aristo Pharmaceuticals was founded in 1971.
Aristo Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Aristo Pharmaceuticals has 4,171 employees.
The primary company behind Aristo Pharmaceuticals, Aristo Pharmaceuticals Private Limited, reported revenue of ₹5,363 Cr for FY 2025, up 5% year on year.
It is observed that Aristo Pharma is positioned as a key player in the Indian pharmaceutical market, holding ranks such as 3rd in its covered market and 5th in prescription audits, with revenues exceeding 5700 crores as per IQVIA data. The company has launched innovative products like ProGG, the worlds leading probiotic, and has introduced over 21 formulations first in India, spanning areas like anti-infectives and gastro intestinal therapies. Growth is demonstrated through a 10.76 CAGR over five years, supported by a sales force of 5100, while operating with seven marketing divisions to maintain a strong market presence.
Aristo Pharmaceuticals offers ProGG and MONOCEF.
Aristo Pharmaceuticals operates through Aristo Pharmaceuticals Private Limited.
The legal entities of Aristo Pharmaceuticals currently have 3 directors, including Randhir Kumar Bachan, Virendra Sharma, Umesh Sharma.